540 related articles for article (PubMed ID: 19021686)
41. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
42. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
43. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
[TBL] [Abstract][Full Text] [Related]
44. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
[TBL] [Abstract][Full Text] [Related]
45. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
Oguma J; Ozawa S; Koyanagi K; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
Esophagus; 2019 Oct; 16(4):395-401. PubMed ID: 31190104
[TBL] [Abstract][Full Text] [Related]
47. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
Okamura A; Watanabe M; Mine S; Kurogochi T; Yamashita K; Hayami M; Imamura Y; Ogura M; Ichimura T; Takahari D; Chin K
Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859367
[TBL] [Abstract][Full Text] [Related]
48. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus.
Tabira Y; Okuma T; Kondo K; Kitamura N
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):239-45. PubMed ID: 9918963
[TBL] [Abstract][Full Text] [Related]
49. Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases.
Cheng J; Kong L; Huang W; Li B; Li H; Wang Z; Zhang J; Zhou T; Sun H
J Thorac Oncol; 2013 Mar; 8(3):359-65. PubMed ID: 23263689
[TBL] [Abstract][Full Text] [Related]
50. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
[TBL] [Abstract][Full Text] [Related]
51. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
52. The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Miyata H; Tanaka K; Makino T; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
Ann Surg Oncol; 2018 Aug; 25(8):2409-2417. PubMed ID: 29748887
[TBL] [Abstract][Full Text] [Related]
53. Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients.
Ma Q; Liu W; Jia R; Long H; Zhang L; Lin P; Zhao H; Ma G
Oncotarget; 2016 Jun; 7(25):38857-38863. PubMed ID: 27095577
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer.
Bollschweiler E; Hölscher AH; Metzger R; Besch S; Mönig SP; Baldus SE; Drebber U
Ann Thorac Surg; 2011 Dec; 92(6):2020-7. PubMed ID: 22115212
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of lymph node metastasis in surgical resection of esophageal cancer.
Sun K; Zhang R; Zhang D; Huang G; Wang L
Chin Med J (Engl); 1996 Jan; 109(1):89-92. PubMed ID: 8758378
[TBL] [Abstract][Full Text] [Related]
56. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma.
Niwa Y; Koike M; Hattori M; Iwata N; Takami H; Hayashi M; Tanaka C; Kobayashi D; Kanda M; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23(2):611-8. PubMed ID: 26289807
[TBL] [Abstract][Full Text] [Related]
57. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
Zhang HL; Chen LQ; Liu RL; Shi YT; He M; Meng XL; Bai SX; Ping YM
Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
[TBL] [Abstract][Full Text] [Related]
58. Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell Carcinoma.
Huang J; Hu W; Pang L; Chen J; Yang H
Oncol Res Treat; 2015; 38(9):424-8. PubMed ID: 26406168
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Liu DT; Chen YP; Zhang H
J Thorac Oncol; 2013 Apr; 8(4):495-501. PubMed ID: 23446203
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy.
Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
J Surg Oncol; 2015 Jul; 112(1):60-5. PubMed ID: 26179950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
